FDA approves new Johnson & Johnson drug for depression

Mar 6, 2019
The Food and Drug Administration has approved the first new kind of drug to treat depression since Prozac hit the scene in the late 1980s. Spravato¬†is a nasal spray from Johnson & Johnson that’s a close cousin of ketamine, an…
Janssen Pharmaceutica

We’re here for you.

As COVID-19 reshapes our economy, our newsletter will help you unpack the news from the day.